ArticleTherapeutics and clinical risk management2023

Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes.

Na Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.